课题基金 / 基金详情

EXPERIMENTAL RADIATION ONCOLOGY CONFERENCE

EXPERIMENTAL RADIATION ONCOLOGY CONFERENCE
实验放射肿瘤学会议
批准号:
3434176
负责人:
MILTON B YATVIN
金额:
$0.2万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1992-07-31

项目摘要

项目成果

MILTON B YATVIN的其他基金

相关文献

中文摘要
翻译
首席调查员在被任命为首席调查员时启动了这一计划 俄勒冈健康科学大学放射肿瘤学系 首届“OHSU实验放射肿瘤学会议”于3月16日召开 和17岁的。他之前作为两个类似的 1975年和1981年在麦迪逊威斯康星大学的会议 为第一次波特兰会议的成功作出了巨大贡献。这个 科学界和医学界对第一个问题的反应 俄勒冈州会议(所附计划表明波特兰和 西北大学的一个论坛,它将提供一个综合的癌症方法- 相关主题。会议的刺激和最近启动的 OHSU校园的放射生物学项目增加了当地的兴趣和 了解实验性癌症研究。继续这些“试验性” 放射肿瘤学会议“将进一步增加这种兴趣,并 意识。参加1989年波特兰会议的不仅仅是当地人士。它 涉及全州的医疗和研究社区以及参与者 来自其他州和欧洲的人,这为 来自波特兰(和西海岸各州)的研究人员交流 被邀请的演讲者的想法被选为他们的创新工作。一批 国际公认的工人能够参加波特兰 会议,因为它被安排为辐射的卫星 研究会议。这样的联系将被保留,以最大限度地提高效益 同时将受邀演讲者的旅行费用保持在可接受的水平。 第一次会议的经费主要由“克利福德五世”提供。 为表彰OHSU第一任辐射主席而设立的“艾伦”基金 他退休时在肿瘤科工作。这个基金,和其他有限的地方 资源,现在不足以支持再举行一次会议。现在 赠款申请认识到有必要继续这些会议,并 在第一次会议成功的基础上再接再厉。其主要目标将是 激发俄勒冈州医生和医学科学家对 具有潜在治疗作用的研究领域的进展 这意味着什么。每一次会议都将提供一种综合办法, 选定的主题,预计这将证明特别的 引起当地临床医生的兴趣。会议的形式和相对的 少量参与者(60-80人)将最大限度地增加 不同参与者之间的互动讨论。 下一次会议的主题是“固有的细胞敏感性和 获得对辐射、高温和药物的抵抗力。这是临床上的 的重要性,也是当前研究兴趣的焦点 包括基础和应用两个层面。中会议的主题 随后的几年是“新的治疗方法的生物学基础”和 “分子生物学在癌症治疗中的作用”。
英文摘要
The Principle Investigator initiated this program on his appointment to the Radiation Oncology Department of Oregon Health Sciences University with the first "OHSU Experimental Radiation Oncology Conference" held on March 16th and 17th 1989. His prior experience as the organizer of two similar meetings at the University of Wisconsin, Madison in 1975 and 1981 contributed greatly to the success of the first Portland Conference. The response by both the scientific and medical communities to this first Oregon meeting (program enclosed demonstrated a need in Portland and the Northwest for a forum which would provide an integrated approach to cancer- related topics. The stimulus of the meeting and the recent initiation of a radiobiology program on the OHSU campus has increased local interest and awareness of experimental cancer studies. Continuing these "Experimental Radiation Oncology Conferences" would further increase this interest and awareness. Attendance at the 1989 Portland meeting was not only local. It involved the medial and research communities state-wide and participants both from out of state and from Europe and this provided an opportunity for researchers from Portland (and the West Coast States generally) to exchange ideas with invited speakers chosen for their innovative work. A number of internationally recognized workers were able to attend the Portland Conference as it had been scheduled as a satellite of the 1989 Radiation Research meeting. Such a link will be retained to maximize the benefits while keeping travel costs for invited speakers to an acceptable level. Funds for the first conference were primarily provided by the "Clifford V. Allen" fund set up to honor the first Chairman of the OHSU Radiation Oncology Department on his retirement. This fund, and other limited local resources, are now insufficient to support a further meeting. The present grant request recognizes the need to continue these conferences and to build on the success of the first meeting. The primary aim will be to stimulate awareness among Oregon physicians and medial scientists of developments in research fields which have potential therapeutic implications. Each Conference will provide an integrated approach to the topic chosen and it is anticipated that this will prove of particular interest to local clinicians. The format of the meeting and the relatively small number of participants (60-80) will maximize opportunities for interactive discussion between the various participants. The topic for the next meeting is "Intrinsic cellular sensitivity and acquired resistance to radiation, heat and drugs". this is of clinical importance and also the focus of substantial current research interest at both the basic and the applied level. The topics for meetings in subsequent years are "Biological bases of novel therapeutic approaches" and "The role of molecular biology in cancer treatments".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USING LIPID LINKED AZT DRUGS TO IMPROVE HIV THERAPY
  • 批准号:
    2422870
  • 项目类别:
  • 资助金额:
    $9.95万
  • 财政年份:
    1997
  • 负责人:
    MILTON B YATVIN
  • 依托单位:
ROLE OF MEMBRANE LIPIDS IN HEAT INJURY
MEMBRANE LIPIDS AND HEAT INJURY
ROLE OF MEMBRANE LIPIDS IN HEAT INJURY